Short answer
DENTSPLY SIRONA Inc (XRAY) filed an 8-K current report with the SEC on February 24, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). Board expanded from 11 to 13 directors; James D. Forbes and Brian P. McKeon appointed effective Feb 27, 2026.
DENTSPLY SIRONA Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Board expanded from 11 to 13 directors; James D. Forbes and Brian P. McKeon appointed effective Feb 27, 2026
- Forbes joins Compensation & Human Capital Committee; McKeon joins Audit & Finance and Science & Technology Committees
- Both new directors receive standard non-employee board compensation per April 2025 proxy filing
- Director Willie A. Deese will not seek reelection at 2026 annual meeting; departure not due to any disagreement with the Company
Item 7.01 · Regulation FD Disclosure
- Forbes and McKeon appointed to Dentsply Sirona Board of Directors
- Director Deese will not seek reelection, signaling board composition shift
- Board changes may reflect ongoing strategic review or investor/activist pressure at XRAY
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other DENTSPLY SIRONA Inc 8-K filings
Get the next XRAY 8-K as it lands
Follow XRAY for push alerts, or ask the research agent what this filing means.